Exploration of Drug Science

Open Access Original Article

Luminescent iridium(III)-pyridyl based complexes: tumor inhibitory studies in 4T1 mammary carcinoma mice model

Natesan Sundarmurthy Karthikeyan ... Vasanthakumaran Sudarsan

Published: April 28, 2026 Explor Drug Sci. 2026;4:1008158

DOI: https://doi.org/10.37349/eds.2026.1008158

Full Text PDF

64 9 0

Open Access Original Article

Chitosan-based nanoparticles fabricated by ionotropic gelation using two types of polyphosphates: characterization and in-vitro release modeling of curcumin

Ilya Eydelman ... Amnon C. Sintov

Published: April 15, 2026 Explor Drug Sci. 2026;4:1008157

DOI: https://doi.org/10.37349/eds.2026.1008157

Full Text PDF

333 17 0

Open Access Original Article

Quality control assessment of bisoprolol fumarate scored tablet products available in Saudi Arabia

Doaa Hasan Alshora ... Hamzah M. Maswadeh

Published: April 01, 2026 Explor Drug Sci. 2026;4:1008156

DOI: https://doi.org/10.37349/eds.2026.1008156

Full Text PDF

535 19 0

Open Access Review

Journey of therapeutic antibodies: from discovery to future

Abhay H. Pande ... J. Anakha

Published: March 19, 2026 Explor Drug Sci. 2026;4:1008155

DOI: https://doi.org/10.37349/eds.2026.1008155

Full Text PDF

1959 47 0

Open Access Perspective

Updates on intranasal nanomedicine design for central nervous system disease treatment

Rui Yang ... Xuejuan Zhang

Published: March 10, 2026 Explor Drug Sci. 2026;4:1008154

DOI: https://doi.org/10.37349/eds.2026.1008154

This article belongs to the special issue Nanoformulations for Non-Intravenous Drug Delivery

Full Text PDF

1025 17 0

Open Access Correction

Correction: Exploring s-triazine derivatives as anticancer agents

Anamika Sharma ... Ayman El-Faham

Published: March 02, 2026 Explor Drug Sci. 2026;4:1008153

DOI: https://doi.org/10.37349/eds.2026.1008153

Full Text PDF

314 16 0

Open Access Review

Molecular drivers of ageing and emerging longevity therapies

Magaa Lakshmi Dhinakaran ... Dinesh Kumar Srinivasan

Published: February 26, 2026 Explor Drug Sci. 2026;4:1008152

DOI: https://doi.org/10.37349/eds.2026.1008152

Full Text PDF

2991 41 0

Open Access Review

Phytochemical profiles and therapeutic applications of selected medicinal plants: an evidence-based narrative review

Saurabh Dilip Bhandare, Sarika Shivaji Malode

Published: February 25, 2026 Explor Drug Sci. 2026;4:1008151

DOI: https://doi.org/10.37349/eds.2026.1008151

Full Text PDF

1627 35 0

Open Access Original Article

Peptide treatment of human plasma disrupts metabolic and age-related pathologies via heat shock protein 70

Timothy J. Cunningham

Published: February 24, 2026 Explor Drug Sci. 2026;4:1008150

DOI: https://doi.org/10.37349/eds.2026.1008150

This article belongs to the special issue Peptide Science Without Borders: Novel Insights for Drug Discovery

Full Text PDF

821 12 0

Open Access Review

Exploring s-triazine derivatives as anticancer agents

Anamika Sharma ... Ayman El-Faham

Published: February 11, 2026 Explor Drug Sci. 2026;4:1008149

DOI: https://doi.org/10.37349/eds.2026.1008149

This article belongs to the special issue The Role of Triazine Scaffolds in Modern Drug Development

Full Text PDF

2163 64 0

Open Access Original Article

Prophylactic metoclopramide for preventing opioid-induced nausea and vomiting in cancer pain: a retrospective cohort study

Xianglian Ma ... Jiuda Zhao

Published: February 02, 2026 Explor Drug Sci. 2026;4:1008148

DOI: https://doi.org/10.37349/eds.2026.1008148

Full Text PDF

1445 24 0

Open Access Review

Vinyl sulfones: selective and tunable covalent warheads against challenging enzyme targets

Ronald E. Viola

Published: February 01, 2026 Explor Drug Sci. 2026;4:1008147

DOI: https://doi.org/10.37349/eds.2026.1008147

This article belongs to the special issue The Rise of Targeted Covalent Inhibitors in Drug Discovery

Full Text PDF

2356 53 0

Open Access Case Report

A case series of CBT-inspired behavioral and medical interventions for uncontrolled type 2 diabetes

Ahmed Nouri, Bassam Abu Madi

Published: February 01, 2026 Explor Drug Sci. 2026;4:1008146

DOI: https://doi.org/10.37349/eds.2026.1008146

Full Text PDF

1488 21 0

Open Access Original Article

Small molecule and fragment-based phenotypic screening for novel building blocks with antimycobacterial activity

Monika I. Konaklieva ... Balbina J. Plotkin

Published: February 01, 2026 Explor Drug Sci. 2026;4:1008145

DOI: https://doi.org/10.37349/eds.2026.1008145

This article belongs to the special issue Discovery and development of new antibacterial compounds

Full Text PDF

793 19 0

Open Access Systematic Review

Harnessing nanomaterials to overcome antimicrobial resistance in Gram-positive bacteria: a systematic review

Olalekan John Okesanya ... Don Eliseo Lucero-Prisno III

Published: January 28, 2026 Explor Drug Sci. 2026;4:1008144

DOI: https://doi.org/10.37349/eds.2026.1008144

Full Text PDF

2525 34 0

Open Access Systematic Review

Janus-faced role of anti-infective drugs: a revisit through the lens of vascular ageing

Ceaser Wankumbu Silumbwe ... Kebby Mazyamuna

Published: January 14, 2026 Explor Drug Sci. 2026;4:1008143

DOI: https://doi.org/10.37349/eds.2026.1008143

Full Text PDF

1815 31 0

Open Access Correction

Correction: High-risk neuroblastoma stage 4 (NBS4): multi-target inhibitors for c-Src kinases (Csk) and retinoic acid (RA) signalling pathways

Amgad Gerges, Una Canning

Published: January 09, 2026 Explor Drug Sci. 2026;4:1008142

DOI: https://doi.org/10.37349/eds.2026.1008142

Full Text PDF

412 21 0

Open Access Review

Innovative immunotherapies for prostate cancer: understanding the synergies between checkpoint inhibition, CAR T-cell therapy, and next-generation therapeutic modalities

Daniel Kofi Nyame ... Xiaohui Zhou

Published: January 09, 2026 Explor Drug Sci. 2026;4:1008141

DOI: https://doi.org/10.37349/eds.2026.1008141

Full Text PDF

3494 38 0

Open Access Original Article

Multiscale computational profiling of a promising carbapenemase inhibitor: from binding dynamics to quantum reactivity

Ayuba Olanrewaju Mustapha ... Yusuf Oloruntoyin Ayipo

Published: January 09, 2026 Explor Drug Sci. 2026;4:1008140

DOI: https://doi.org/10.37349/eds.2026.1008140

This article belongs to the special issue Discovery and development of new antibacterial compounds

Full Text PDF

1122 21 0

Open Access Systematic Review

Targeted therapeutic management of diabetes using phytoconstituents: molecular mechanisms, evidence map (2015–2025), and translational outlook

Chizurum Philip Ikegbuna ... Mmesoma Ruth Ikegbuna

Published: January 07, 2026 Explor Drug Sci. 2026;4:1008139

DOI: https://doi.org/10.37349/eds.2026.1008139

Full Text PDF

2594 55 0